Generators
Total Payments
$989,741
Transactions
353
Doctors
38
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $50,679 | 16 | 5 |
| 2019 | $127,869 | 98 | 16 |
| 2018 | $352,341 | 80 | 16 |
| 2017 | $458,851 | 159 | 14 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $837,871 | 186 | 84.7% |
| Education | $143,500 | 16 | 14.5% |
| Consulting Fee | $5,100 | 3 | 0.5% |
| Food and Beverage | $2,788 | 147 | 0.3% |
| Travel and Lodging | $482.90 | 1 | 0.0% |
Payments by Type
Research
$837,871
186 transactions
General
$151,871
167 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation IDE#G120289 | Medical Device Business Services, Inc. | $268,927 | 1 |
| reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation IDE # G120289 | Medical Device Business Services, Inc. | $139,369 | 0 |
| Influence of renal deafferentation/denervation on renal neuro transmission and ventricular electrophysiology | Biosense Webster, Inc. | $63,127 | 0 |
| reMARQable nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation | Medical Device Business Services, Inc. | $60,673 | 0 |
| reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation IDE#G120289 | Medical Device Business Services, Inc. | $56,038 | 0 |
| reMARQable: nMARQ? Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation IDE # G120289 | Medical Device Business Services, Inc. | $36,408 | 0 |
| reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation IDE# G120289 | Medical Device Business Services, Inc. | $22,485 | 0 |
| RACE (Registry of American Rhinologic Society Clinical Endpoints) Database | Medical Device Business Services, Inc. | $20,295 | 0 |
| Prospective Safety Assessment of the THERMOCOOL SMARTTOUCH SF Family of Contact Force Sense Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic PAF (SMART-SF) IDE # G1240189 | Medical Device Business Services, Inc. | $20,151 | 0 |
| reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation IDE #G120289 | Medical Device Business Services, Inc. | $17,905 | 0 |
| Prospective Safety Assessment of the THERMOCOOL SMARTTOUCH SF Family of Contact Force Sense Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic PAF (SMART-SF) IDE # G1240189 | Medical Device Business Services, Inc. | $14,061 | 0 |
| reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation IDE # G120289 | Medical Device Business Services, Inc. | $13,965 | 0 |
| Safety of Oral Anticoagulation Therapy Withdrawal after Successful Pulmonary Vein Antrum Isolation in Patients with Atrial Fibrillation and Associated High Risk Factors for Embolic Events | Medical Device Business Services, Inc. | $10,948 | 0 |
| reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation IDE#G 120289 | Medical Device Business Services, Inc. | $9,720 | 0 |
| Safety of Oral Anticoagulation Therapy Withdrawal after Successful Pulmonary Vein Antrum isolation in Patients with Atrial Fibrillation and Associated High Risk Factors for Embolic Events (OAT 149) | Medical Device Business Services, Inc. | $9,400 | 0 |
| reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation | Medical Device Business Services, Inc. | $5,328 | 0 |
| Prospective Safety Assessment of the THERMOCOOL SMARTTOUCH SF Family of Contact Force Sensing Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic PAF SMART SF (STSF-162) IDE# G1240189 | Medical Device Business Services, Inc. | $4,648 | 0 |
| Prospective Safety Assessment of the THERMOCOOL SMARTTOUCH SF Family of Contact Force Sense Catheters for the Radiofrequency Ablation Treatment of Drug Refractory Symptomatic PAF (SMART-SF) | Medical Device Business Services, Inc. | $4,350 | 0 |
| Safety of Oral AnticoagulationTherapy Withdrawal after Successful Pulmonary Vein Antrum isolation in Patients with Atrial Fibrillation and Associated High Risk Factors for Embolic Events (OAT 149) | Medical Device Business Services, Inc. | $3,434 | 0 |
| reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrilation IDe # G12089 | Biosense Webster, Inc. | $3,250 | 0 |
Top Doctors Receiving Payments for Generators
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Rochester, MN | $974,808 | 199 |
| , MD | Cardiovascular Disease | New Smyrna Beach, FL | $6,563 | 3 |
| , M.D | Cardiovascular Disease | San Francisco, CA | $5,100 | 3 |
| , M.D., PH.D | Internal Medicine | Bedford, TX | $482.90 | 1 |
| , MD | Cardiovascular Disease | Austin, TX | $399.33 | 18 |
| , MD | Specialist | Stanford, CA | $308.44 | 19 |
| , M.D | Cardiovascular Disease | Austin, TX | $235.58 | 12 |
| , M.D | Cardiovascular Disease | Austin, TX | $212.35 | 12 |
| , M.D | Cardiovascular Disease | Austin, TX | $194.59 | 7 |
| , DDS | Dentist | Denton, TX | $180.13 | 11 |
| , MD | Cardiovascular Disease | Austin, TX | $168.81 | 10 |
| , M.D | Clinical Cardiac Electrophysiology | Austin, TX | $152.64 | 15 |
| , MD, PHD | Cardiovascular Disease | Bronx, NY | $139.75 | 2 |
| , M.D | Cardiovascular Disease | Austin, TX | $126.95 | 2 |
| , MD | Internal Medicine | Janesville, WI | $98.57 | 1 |
| , M.D | Cardiovascular Disease | Austin, TX | $86.73 | 9 |
| , M.D | Surgery | Omaha, NE | $70.80 | 2 |
| , M.D | Cardiovascular Disease | Sacramento, CA | $60.00 | 1 |
| , M.D | Colon & Rectal Surgery | Miami, FL | $30.34 | 1 |
| , M.D.,F.A.C.S | Surgery | Miami, FL | $30.34 | 1 |
| , M.D | Cardiovascular Disease | Austin, TX | $25.11 | 2 |
| , MD | Cardiovascular Disease | Macon, GA | $24.28 | 1 |
| , MD | Cardiovascular Disease | Valhalla, NY | $20.36 | 3 |
| , MD | Nuclear Cardiology | Arlington, TX | $18.03 | 1 |
| , MD | Internal Medicine | New Haven, CT | $18.03 | 1 |
Ad
Manufacturing Companies
- Medical Device Business Services, Inc. $729,472
- Ethicon US, LLC $143,735
- Biosense Webster, Inc. $116,534
Product Information
- Type Device
- Total Payments $989,741
- Total Doctors 38
- Transactions 353
About Generators
Generators is a device associated with $989,741 in payments to 38 healthcare providers, recorded across 353 transactions in the CMS Open Payments database. The primary manufacturer is Medical Device Business Services, Inc..
Payment data is available from 2017 to 2020. In 2020, $50,679 was paid across 16 transactions to 5 doctors.
The most common payment nature for Generators is "Unspecified" ($837,871, 84.7% of total).
Generators is associated with 20 research studies, including "reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation IDE#G120289" ($268,927).